Caution around the fountain of youth.

Lee et al. do a review "Antiaging diets: Separating fact from fiction" in Science Magazine. The link takes you to their summary, abstract, and a nice graphic. I pass on a Box 1 from the body of the article titled "reclaiming the term 'anti-aging'":

The phrase “antiaging” is greatly abused in popular culture, often for the purpose of marketing cosmetic procedures or unproven nutritional supplements purported to slow or reverse aging. This has the unfortunate consequence of creating confusion among the general public and diminishing the impact of legitimate scientific discovery. Here, we define “antiaging” as delaying or reversing biological aging by targeting the established molecular mechanisms of aging, which have been formalized as “hallmarks” or “pillars” of aging (93, 94). Effective antiaging interventions in laboratory animals increase both median and maximum population life span and broadly delay the onset and progression of many age-related functional declines and diseases. The latter effect is often referred to as “extending health span,” which is a qualitative term referring to the period of life free from chronic disease and disability (95). Recent studies show that at least some antiaging interventions, such as the drug rapamycin, can reverse functional declines across multiple tissues in aged animals (96). On the basis of this definition, there are as yet no clinically validated antiaging interventions in humans. However, there is some evidence consistent with antiaging effects for CR and related diets in humans as well as a small number of putative geroprotective compounds, including metformin and rapamycin (97).

93. C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, G. Kroemer, The hallmarks of aging. Cell 153, 1194–1217 (2013).

94. B. K. Kennedy, S. L. Berger, A. Brunet, J. Campisi, A. M. Cuervo, E. S. Epel, C. Franceschi, G. J. Lithgow, R. I. Morimoto, J. E. Pessin, T. A. Rando, A. Richardson, E. E. Schadt, T. Wyss-Coray, F. Sierra, Geroscience: Linking aging to chronic disease. Cell 159, 709–713 (2014).

95 M. Kaeberlein, How healthy is the healthspan concept? Geroscience 40, 361–364 (2018).

96 R. Selvarani, S. Mohammed, A. Richardson, Effect of rapamycin on aging and age-related diseases-past and future. Geroscience 43, 1135–1158 (2021).

97 M. B. Lee, M. Kaeberlein, Translational Geroscience: From invertebrate models to companion animal and human interventions. Transl. Med. Aging 2, 15–29 (2018).